Stock prices were little changed at midday. Coming off Friday’s record close, the Dow Jones industrial average was up four points at 12,966. The Nasdaq Composite Index had gained more than three points at … via Newsnet5.com

Original post by Newsnet5.com

WASHINGTON: Securities regulators are warning investors to be wary of faxes, e-mails and text messages sent by cell phone that promise huge profit from so-called “China” stocks of companies that often are … via International Herald Tribune

Original post by International Herald Tribune

Highlights included a tenth consecutive quarter of double-digit gains in developing and emerging markets, strong innovation-driven volume growth for the company’s Personal Care business in North America and … via Canada NewsWire

Original post by Canada NewsWire

AstraZeneca Plc has agreed to buy U.S. biotechnology company MedImmune Inc. for more than $15 billion in the biggest transaction since the creation of the Anglo-Swedish drugs group in 1999. via Boston.com

Original post by Boston.com

Author Message What is the reason behind the stock market continuing to climb. Could the devaluing of dollar vs virtually all other currencies; allow the stock market to continue to climb? The rising stock … via Peakoil.com

Original post by Peakoil.com

Some biotechnology companies that are busy developing tomorrow’s blockbuster medications will end up delivering powerful long-term performances. via Springfield News Leader

Original post by Springfield News Leader